98 related articles for article (PubMed ID: 10192493)
1. Rapid progression of squamous cell carcinoma of the cervix after hyperbaric oxygenation.
Wang PH; Yuan CC; Lai CR; Chao HT; Tseng JY; Chiang H; Lee WL; Lee SD; Ng HT
Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):89-91. PubMed ID: 10192493
[TBL] [Abstract][Full Text] [Related]
2. Optimal therapy for relapsed carcinoma of the cervix after primary chemoradiation.
Mano M; Kerr J
J Clin Oncol; 2004 Dec; 22(24):5021-2; author reply 5022. PubMed ID: 15611523
[No Abstract] [Full Text] [Related]
3. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Yin YJ; Li HQ; Sheng XG; Du XL; Wang C; Lu CH; Pan CX
Int J Gynecol Cancer; 2015 Jul; 25(6):1058-65. PubMed ID: 25647254
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer.
Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N
Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856
[TBL] [Abstract][Full Text] [Related]
7. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
8. Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy.
Linghu H; Xu XR; Mei YY; Tang JY; Tang LD; Sun T
Chin Med Sci J; 2004 Jun; 19(2):116-9. PubMed ID: 15250247
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
Matsui R; Kashihara K; Higashi T; Seo K; Taoka Y; Yoshida S; Nishitani H; Takegawa Y; Hukumura Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1985-8. PubMed ID: 8978808
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy with cisplatin and bleomycin in advanced cervical cancer.
Bloch B; Nel CP; Kriel A; Atad J; Goldberg G
Cancer Treat Rep; 1984 Jun; 68(6):891-3. PubMed ID: 6203640
[TBL] [Abstract][Full Text] [Related]
11. Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.
Malfetano J; Keys H; Kredentser D; Cunningham M; Kotlove D; Weiss L
Cancer; 1993 Jun; 71(11):3703-6. PubMed ID: 8387884
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Smith HO; Stringer CA; Kavanagh JJ; Gershenson DM; Edwards CL; Wharton JT
Gynecol Oncol; 1993 Jan; 48(1):11-5. PubMed ID: 7678571
[TBL] [Abstract][Full Text] [Related]
13. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
14. [Glassy cell carcinoma of the cervix].
Dieterle S; Mesrogli M; Günter HH; Kühnle H
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):484-5. PubMed ID: 1909675
[TBL] [Abstract][Full Text] [Related]
15. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
[TBL] [Abstract][Full Text] [Related]
16. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
17. [Systemic therapy in recurrent and primary advanced cervix cancer].
Kaufmann M; Schmid H; Junkermann H; Schönig T; von Fournier D; Bastert G
Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):454-62. PubMed ID: 1716240
[TBL] [Abstract][Full Text] [Related]
18. Cisplatinum combined with etoposide. Effective therapy for metastasised squamous-cell carcinoma of the cervix.
Bouvy JJ; Braun JJ; Ruit JB
Eur J Gynaecol Oncol; 2011; 32(6):689-90. PubMed ID: 22335039
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.
Picozzi VJ; Sikic BI; Carlson RW; Koretz M; Ballon SC
Cancer Treat Rep; 1985; 69(7-8):903-5. PubMed ID: 2410123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
